Galia Meiri, M.D.
NPI 1275512832 · Specialist · Reno, NV
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Galia Meiri, M.D. is a Specialist provider in Reno, NV (NPI 1275512832).
Provider details
- NPI number
- 1275512832
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 214031 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,720 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 492 | $7 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 303 | $125 |
| Biopsy of Related Skin Growth, First Growth11102 | 186 | $91 |
| Destruction of Skin Growth, 1-14 Growths17110 | 168 | $111 |
| Biopsy of Related Skin Growth, Each Additional Growth11103 | 144 | $49 |
| Destruction of Precancer Skin Growth, 1 Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 97 | 49 |
| Mupirocin | 80 | 62 |
| Triamcinolone Acetonide | 76 | 57 |
| Clobetasol Propionate | 51 | 32 |
| Nystatin | 27 | 21 |
| Valacyclovir Hclbrand: Valacyclovir | 27 | 22 |
| Fluocinonide | 24 | 13 |
| Tacrolimus | 23 | 12 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,830 across 71 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-12
- Last updated
- 2024-07-08
- Certified
- 2024-07-08
Frequently asked questions
- What is Galia Meiri's NPI number?
- Galia Meiri's National Provider Identifier (NPI) is 1275512832, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Galia Meiri's specialty?
- Galia Meiri is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Galia Meiri located?
- Galia Meiri's practice location on file with NPPES is 650 Sierra Rose Dr Ste a, Reno, NV 89511-2081.
- What is Galia Meiri's phone number?
- The practice phone number listed in the NPPES registry for Galia Meiri is (775) 827-8100.
- Does Galia Meiri accept Medicare?
- Galia Meiri is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Galia Meiri's NPI active?
- Yes — Galia Meiri's NPI (1275512832) is active in the NPPES registry as of the last update on 2024-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.